The Company at its Board meeting held today on February 12, 2026 for the consideration and approval of the Unaudited Standalone and Consolidated Financial Statements of the Company for the Third quarter ended December 31, 2025, which had been duly reviewed and recommended by the Audit Committee along with the Limited Review Report thereon.
MANORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mangalam Organics reported its Q3 FY26 results for the quarter ended December 31, 2025, approved by the Board on February 12, 2026. On a consolidated basis, revenue from operations stood at ₹16,429.84 lakhs, up about 33% year-on-year from ₹12,391.66 lakhs, while nine-month revenue grew 23% to ₹46,895.36 lakhs. Nine-month consolidated profit after tax jumped to ₹1,976.48 lakhs from ₹743.21 lakhs, with EPS rising to ₹23.08 from ₹8.68. Standalone revenue grew about 22% YoY to ₹12,244.57 lakhs in Q3, but quarterly pre-tax profit fell sharply to ₹149.82 lakhs from ₹378.80 lakhs a year ago. An exceptional item of ₹350.60 lakhs was recorded in the previous quarter (Q2 FY26), with none in Q3. The auditor (NGST & Associates) issued an unmodified limited review report on both sets of results.
Strong 9-month PAT growth (standalone ~78%, consolidated ~166%) and robust revenue expansion are positive for shareholders, though the sharp YoY dip in quarterly standalone profit despite higher revenue signals margin pressure that investors should watch closely.